P01308 (INS_HUMAN) Homo sapiens (Human)
Insulin UniProtKBInterProSTRINGInteractive Modelling
110 aa; Sequence (Fasta) ;
2 identical sequences: Homo sapiens: I3WAC9; Gorilla gorilla gorilla: Q6YK33
Available Structures
357 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| 0.92A structure of 2Zn human insulin at 100K |
Heteromer | 100 | 3×ZN; | |||
| X-ray Structure of Human Recombinant 2Zn insulin at 0.92 Angstrom |
Heteromer | 100 | 6×ZN; 3×ACT; 3×POL; | |||
| Insulin with proline analog HzP at position B28 in the T2 state |
Heteromer | 100 | ||||
| T6 Human Insulin at 1.0 A Resolution |
Heteromer | 100 | 6×ZN; | |||
| High resolution structure of the manganese derivative of insulin |
Heteromer | 100 | 1×NA; 1×MN; | |||
| Crystal Structure Analysis of Cu Human Insulin Derivative |
Heteromer | 100 | ||||
| 1.15A structure of human 2Zn insulin at 293K |
Heteromer | 100 | 3×ZN; | |||
| Crystal structure of D-ProB26-DTriA analogue of human insulin |
Heteromer | 96.15 | ||||
| Insulin with proline analog Pip at position B28 in the T2 state |
Heteromer | 100 | 2×NA; | |||
| Insulin with proline analog FyP at position B28 in the T2 state |
Heteromer | 100 | ||||
| Insulin with proline analog DhP at position B28 in the T2 state |
Heteromer | 100 | 2×NA; | |||
| 1.2 A structure of T3R3 human insulin at 100 K |
Heteromer | 100 | 15×ZN; 12×CL; | |||
| Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… |
Heteromer | 100 | 2×16E; 6×RCO; 2×NA; 3×IMD; 2×ZN; | |||
| Cubic Insulin SAD phasing at 14.2 keV |
Heteromer | 100 | ||||
| Insulin with proline analog ThioP at position B28 in the T2 state |
Heteromer | 100 | ||||
| X-Ray structure of Insulin Analog GLULISINE |
Heteromer | 100 | 6×ZN; | |||
| Insulin glulisine |
Heteromer | 100 | 6×ZN; 6×FMT; | |||
| Insulin with proline analog HzP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Insulin with proline analog AzeP at position B28 in the T2 state |
Heteromer | 100 | 2×NA; | |||
| 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K |
Heteromer | 100 | 15×ZN; 12×CL; | |||
| The structure of a mutant insulin uncouples receptor binding from protein allostery. An electrostat… |
Heteromer | 100 | 6×ZN; | |||
| Insulin with proline analog FzP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; 6×NA; 1×GOL; 1×ACN; | |||
| Insulin with proline analog HyP at position B28 in the T2 state |
Heteromer | 100 | 2×NA; 2×GOL; | |||
| High resolution x-ray crystal structure of synthetic insulin lispro |
Heteromer | 100 | 3×IPH; 1×ZN; 1×CL; | |||
| Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and t… |
Heteromer | 95.0 | 1×ZN; | |||
| Xray crystal structure of isotope-labeled human insulin |
Heteromer | 100 | ||||
| Structure of the T6 human insulin derivative with nickel at 1.35 A resolution |
Heteromer | 100 | 1×NI; 1×NA; | |||
| Zinc free, dimeric human insulin determined to 1.35 Angstrom resolution |
Heteromer | 100 | 2×EDO; | |||
| Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea |
Heteromer | 100 | 2×NA; 6×RCO; 8×URE; 2×ZN; 2×CL; 4×ARF; | |||
| Monoclinic human insulin in complex with p-coumaric acid |
Heteromer | 100 | 2×ZN; 3×PO4; 5×HC4; 1×SCN; | |||
| Crystal structure of human insulin mutant B20 D-ala, B23 D-ala |
Heteromer | 100 | ||||
| Crystal structure of dodecamer human insulin with double C-axis length of the hexamer 2 Zn insulin … |
Heteromer | 100 | 6×ZN; | |||
| Crystal structure of insulin detemir |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; 6×MYR; | |||
| Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form II |
Heteromer | 100 | 1×SO4; 1×ACT; | |||
| Crystal structure of human insulin, crystallised in the presence of macrophage migration inhibitory… |
Heteromer | 100 | 1×SO4; 2×GOL; | |||
| INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE |
Heteromer | 100 | 1×ZN; | |||
| Crystal structure of desB30 insulin produced by cell free protein synthesis |
Heteromer | 100 | ||||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Insulin co-crystallizes in the presence of it beta-cell chaperone sulfatide |
Heteromer | 100 | 6×ZN; 6×CL; 3×NA; | |||
| Crystal structure of an cyclohexylalanine substituted insulin analog. |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Human insulin analogue (D-ProB8)-insulin |
Heteromer | 100 | 2×CL; | |||
| insuline(60sec) and UV laser excited fluorescence |
Heteromer | 100 | ||||
| Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)ami… |
Heteromer | 95.24 | 3×IMD; 3×KUT; | |||
| High resolution x-ray crystal structure of isotope-labeled ester-insulin |
Heteromer | 100 | ||||
| Semi-synthetic analogue of human insulin NMeTyrB26-insulin in hexamer form |
Heteromer | 100 | 6×IPH; 2×CL; 2×ZN; 1×GOL; | |||
| STRUCTURE OF INSULIN |
Heteromer | 100 | 1×CRS; 1×ZN; 1×CL; | |||
| Structure of human insulin cocrystallized with protamine and urea |
Heteromer | 100 | 2×NA; 6×CRS; 12×URE; 10×ARF; 2×ZN; 2×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human insulin with intra-chain chemical crosslink between modified B27 and B30 |
Heteromer | 100 | 10×IPH; 2×ZN; 2×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| A6-A11 trans-dicarba human insulin |
Heteromer | 90.48 | ||||
| Recombinant Human Insulin |
Heteromer | 100 | ||||
| Human insulin B26Phe mutant crystal structure |
Heteromer | 100 | 1×SO4; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL |
Heteromer | 100 | 2×IPH; 1×ZN; 1×CL; | |||
| CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER |
Heteromer | 100 | 1×ZN; 1×CL; | |||
| High resolution crystal structure of racemic ester insulin |
Heteromer | 100 | 2×PEG; 1×GOL; | |||
| Structure of human insulin |
Heteromer | 100 | 1×ZN; 1×CL; | |||
| Human insulin |
Heteromer | 100 | ||||
| Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-actin… |
Heteromer | 100 | 6×CRS; 6×UZ9; 6×ZN; 6×CL; | |||
| Structure of LysB29(Nepsilon omega-carboxyheptadecanoyl) des(B30) Human Insulin |
Heteromer | 100 | 6×RCO; 6×ZN; 6×CL; | |||
| Four-Disulfide Insulin Analog A22/B22 |
Heteromer | 100 | 7×IPH; 2×ACN; 2×ZN; 2×CL; 2×GOL; | |||
| Insulin Lispro Analog |
Heteromer | 100 | 7×CRS; 2×ZN; 2×GOL; 2×CL; | |||
| Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation. |
Heteromer | 100 | 1×SO4; | |||
| Human insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Insulin single mutant INS-Q |
Heteromer | 100 | 2×SO4; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human insulin with intra-chain chemical crosslink between modified B24 and B29 |
Heteromer | 100 | 1×SO4; | |||
| Structure of human insulin in presence of urea at pH 7.0 |
Heteromer | 100 | 8×RCO; 7×URE; 2×ZN; 5×CL; 1×GOL; | |||
| Crystal Structure of human zinc insulin at pH 5.5 |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Structure of human insulin in presence of thiocyanate at pH 7.0 |
Heteromer | 100 | 6×RCO; 2×ZN; 2×SCN; 1×GOL; | |||
| Crystal structure of insulin |
Heteromer | 100 | 3×IPH; 2×ZN; 2×CL; 2×MYR; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form I |
Heteromer | 100 | ||||
| Crystalization of human zinc insulin at pH 5.5 |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Structure of human insulin |
Heteromer | 100 | 1×ZN; 1×CL; | |||
| Serial Macromolecular Crystallography at ALBA Synchrotron Light Source - Insulin |
Heteromer | 100 | 1×ZN; 1×CL; | |||
| Crystal Structure of the cobalt human insulin derivative |
Heteromer | 100 | 1×CO; | |||
| Structural and biophysical characterization of a covalent insulin dimer formed during storage of ne… |
Heteromer | 100 | ||||
| Crystal structure of aspart insulin at pH 6.5 |
Heteromer | 100 | 6×CRS; 6×ZN; 6×CL; | |||
| Structure of the rhombohedral form of the M-cresol/insulin R6 hexamer |
Heteromer | 100 | 9×CRS; 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| STRUCTURE OF INSULIN |
Heteromer | 100 | 1×IPH; 1×ZN; 1×CL; 1×MYR; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… |
Heteromer | 100 | 3×ZN; | |||
| Crystal structure form ultalente insulin microcrystals |
Heteromer | 100 | 6×ZN; 12×CL; | |||
| Crystal structure of human zinc insulin at pH 6.5 |
Heteromer | 100 | 6×ZN; 6×CL; 3×MG; | |||
| Structure of gadolinium-caged cobalt (III) insulin hexamer |
Heteromer | 100 | 6×CO; 3×GD; 3×CL; | |||
| Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of A8… |
Heteromer | 95.24 | 3×ZN; 3×CL; | |||
| Crystal structure of human insulin, crystallised in the presence of macrophage migration inhibitory… |
Heteromer | 100 | 1×SO4; | |||
| Human insulin B26Asn mutant crystal structure |
Heteromer | 100 | ||||
| Human insulin analog: [GluB10,HisA8,ArgA9]-DOI |
Heteromer | 90.48 | ||||
| Human insulin |
Heteromer | 100 | ||||
| Crystal structure of human insulin with Ni+2 complex |
Heteromer | 100 | 6×NI; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Crystal structure of aspart insulin at pH 6.5 |
Heteromer | 100 | 6×CRS; 6×ZN; 6×CL; | |||
| Human insulin in complex with serotonin and arginine |
Heteromer | 100 | 6×ZN; 6×CL; 3×ARG; 3×SRO; | |||
| NMePheB25 insulin analogue crystal structure |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Human insulin with intra-chain chemical crosslink between modified B27 and B29 |
Heteromer | 100 | ||||
| The structure of the resorcinol/insulin R6 hexamer |
Heteromer | 100 | 8×RCO; 2×ZN; 2×CL; 1×NA; | |||
| THE STRUCTURE OF A COMPLEX OF HEXAMERIC INSULIN AND 4'-HYDROXYACETANILIDE |
Heteromer | 100 | 1×ZN; | |||
| CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN |
Heteromer | 100 | 1×ZN; | |||
| Crystal structure of humnan insulin Sr+2 complex |
Heteromer | 100 | 6×SR; | |||
| THE STRUCTURE OF A COMPLEX OF HEXAMERIC INSULIN AND 4'-HYDROXYACETANILIDE |
Heteromer | 100 | 1×ZN; | |||
| Enhancing the Therapeutic Properties of a Protein by a Designed Zinc-Binding Site, Structural princ… |
Heteromer | 90.48 | 9×ZN; 6×CL; 3×IPH; | |||
| Structure of the monoclinic form of the M-cresol/insulin R6 hexamer |
Heteromer | 100 | 7×CRS; 2×ZN; 2×CL; 1×NA; | |||
| Crystal structure of human zinc insulin at pH 6.5 |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Dehydrated T6 human insulin at 100 K |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| insuline(1sec) and UV laser excited fluorescence |
Heteromer | 100 | ||||
| TyrB25,NMePheB26,LysB28,ProB29-insulin analogue crystal structure |
Heteromer | 100 | 6×IPH; 2×CL; 2×ZN; | |||
| Structure of human insulin in presence of thiocyanate at pH 6.5 |
Heteromer | 100 | 6×RCO; 2×ZN; 2×SCN; | |||
| A novel covalently linked insulin dimer |
Heteromer | 100 | ||||
| Structure of Human Arg-Insulin |
Heteromer | 100 | 6×ZN; | |||
| Structure DeltaA1-A4 insulin |
Heteromer | 100 | 6×RCO; 2×ZN; 2×CL; | |||
| Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of pro… |
Heteromer | 85.71 | 6×ZN; 6×CL; 3×IPH; | |||
| INSULIN, MONOCLINIC CRYSTAL FORM |
Heteromer | 100 | 7×IPH; 2×ZN; 2×CL; | |||
| Crystal structure of ni human ARG-insulin |
Heteromer | 100 | 12×NI; 3×NA; 3×CL; | |||
| HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL |
Heteromer | 100 | 6×RCO; 2×ZN; 2×CL; | |||
| Insulin Icodec - A14E B16H B25H B29Ne-C20 diacid-LgGlu-2xAdo desB30 human insulin |
Heteromer | 95.24 | 2×ACT; | |||
| Insulin fibrillation is the Janus face of induced fit. A chiaral clamp stabilizes the native state … |
Heteromer | 100 | 3×ZN; 3×CL; | |||
| CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANIS… |
Heteromer | 100 | 3×ZN; | |||
| Crystal structure of an unstable insulin analog with native activity. |
Heteromer | 95.24 | 6×ZN; | |||
| Crystal Structure Analysis of the Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; 3×GOL; | |||
| Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… |
Heteromer | 100 | 3×IPH; 3×16E; 3×ZN; 3×CL; | |||
| Human insulin in complex with cucurbit[7]uril |
Heteromer | 100 | ||||
| Structure of human insulin in presence of urea at pH 6.5 |
Heteromer | 100 | 6×RCO; 6×URE; 2×ZN; 2×CL; | |||
| T3R3 form of Human insulin with single Zn |
Heteromer | 100 | 6×CRS; 3×NA; 3×ZN; 3×CL; | |||
| Insulin with proline analog PiP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; | |||
| Crystal structure of RB human arg-insulin |
Heteromer | 100 | 3×NA; 3×RB; | |||
| Structural properties of the B25Tyr-NMe-B26Phe insulin mutant. |
Heteromer | 100 | 6×IPH; 2×ZN; | |||
| Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 7.5 |
Heteromer | 100 | ||||
| Crystal Structure of Human Insulin complexed with Cu+2 metal ion |
Heteromer | 100 | 6×CU; | |||
| Insulin with proline analog HyP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; | |||
| Monoclinic crystalline form of human insulin, complexed with meta-cresol |
Heteromer | 100 | 6×CRS; 6×EDO; 2×ZN; 2×IS8; | |||
| Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of pro… |
Heteromer | 100 | 6×ZN; 3×IPH; 3×CL; | |||
| Human insulin in complex with serotonin |
Heteromer | 100 | 6×ZN; 6×CL; 3×SRO; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Structure of human insulin cocrystallized with protamine |
Heteromer | 100 | 6×RCO; 2×ZN; 2×CL; | |||
| Crystal structure of MN human arg-insulin |
Heteromer | 100 | 6×MN; 6×CL; | |||
| Dehydrated T6 human insulin at 295 K |
Heteromer | 100 | 2×ZN; | |||
| Insulin with proline analog DfP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Insulin analog containing a YB26W mutation |
Heteromer | 100 | 6×ZN; 3×IPH; 3×CL; | |||
| Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… |
Heteromer | 100 | ||||
| Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal… |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| LYS(B28)PRO(B29)-HUMAN INSULIN |
Heteromer | 100 | 1×ZN; | |||
| Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies o… |
Heteromer | 95.24 | 3×IPH; 3×ZN; 3×CL; | |||
| Crystal Structure of an iodinated insulin analog |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Insulin fibrillation is the Janus face of induced fit. A chiral clamp stabilizes the native state a… |
Heteromer | 100 | 3×IPH; 3×ZN; 3×CL; | |||
| Human insulin in complex with the analytical antibody S1 Fab |
Heteromer | 100 | 2×NAG; | |||
| HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR |
Heteromer | 100 | 6×ZN; 3×CL; | |||
| Crystal structure of aspart insulin at pH 8.5 |
Heteromer | 100 | 6×CRS; 6×ZN; 6×CL; | |||
| Insulin with proline analog DhP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; | |||
| HUMAN INSULIN MUTANT SERB9GLU |
Heteromer | 100 | ||||
| Crystal structure of LysB22-AspB28 insulin analog at ambient structure |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Non-standard Design of Unstable Insulin Analogues with Enhanced Activity |
Heteromer | 95.24 | 3×ZN; | |||
| Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal… |
Heteromer | 100 | 6×ZN; 6×CL; 3×IPH; | |||
| Crystal structure of aspart insulin at pH 8.5 |
Heteromer | 100 | 6×CRS; 6×ZN; 6×CL; | |||
| Crystal structure of aspart insulin at pH 6.5 |
Heteromer | 100 | 6×CRS; 6×ZN; 6×CL; | |||
| Semi-synthetic analogue of human insulin ProB26-DTI |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SC… |
Heteromer P06213; | 100.0 | 2×NAG; 1×NAG; 1×NAG; 1×SO4; 1×GOL; 1×NAG; | |||
| crystal structure of human insulin degrading enzyme in complex with iodinated insulin |
Heteromer P14735; | 100 | 1×ZN; 4×DIO; | |||
| Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 |
Heteromer P06213; | 100 | 1×NAG; 2×NAG; 2×NAG; | |||
| Human insulin in complex with the analytical antibody S1 Fab and the analytical antibody HUI-001 Fab |
Heteromer | 100 | ||||
| HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES |
Heteromer | 90.48 | ||||
| Enhancing the activity of insulin by stereospecific unfolding |
Heteromer | 100 | ||||
| Structure and dynamics of des-pentapeptide-insulin in solution: the molten-globule hypothesis. |
Heteromer | 100 | ||||
| Solution structure of the [AibB8,LysB28,ProB29]-insulin analogue |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES |
Heteromer | 100 | ||||
| NMR structure of human insulin mutant glu-b21-d-glu, his-b10 asp pro-b28-lys, lys-b29-pro, 20 struc… |
Heteromer | 100 | ||||
| FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA |
Heteromer | 100 | 4×ZN; 4×CL; 2×NA; | |||
| INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 STRUCTURES |
Heteromer | 95.24 | ||||
| THREE-DIMENSIONAL SOLUTION STRUCTURE OF AN INSULIN DIMER. A STUDY OF THE B9(ASP) MUTANT OF HUMAN IN… |
Heteromer | 100 | ||||
| NMR structure of human insulin mutant GLY-B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structur… |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 ST… |
Heteromer | 100 | ||||
| PARADOXICAL STRUCTURE AND FUNCTION IN A MUTANT HUMAN INSULIN ASSOCIATED WITH DIABETES MELLITUS |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO… |
Heteromer | 90.48 | ||||
| Structure of full-length human insulin fibrils |
Heteromer | 100 | ||||
| NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16) |
Heteromer | 100 | ||||
| Solution structure of human insulin at pH 1.9 |
Heteromer | 100 | ||||
| Modified A22Gly-B31Arg Human Insulin |
Heteromer | 100 | ||||
| R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE STRUCTURE |
Heteromer | 100 | 6×IPH; | |||
| R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'GREEN' SUBSTATE, AVERAGE STRUCTURE |
Heteromer | 100 | 6×IPH; | |||
| R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE |
Heteromer | 100 | 6×IPH; | |||
| R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES |
Heteromer | 100 | 6×IPH; | |||
| R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES |
Heteromer | 100 | 2×ZN; 6×IPH; | |||
| Crystal structure of insulin hexamer fitted into cryo EM density map where each dimer was kept as r… |
Heteromer | 100 | ||||
| Solution structure of B24G insulin |
Heteromer | 100 | ||||
| NMR structure of B25-(alpha, beta)-dehydro-phenylalanine insulin |
Heteromer | 100 | ||||
| NMR structure of human insulin mutant gly-b8-d-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 struc… |
Heteromer | 100 | ||||
| R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES |
Heteromer | 100 | 2×ZN; 6×IPH; | |||
| allo-ThrA3 DKP-insulin |
Heteromer | 95.24 | ||||
| ThrA3-DKP-insulin |
Heteromer | 95.24 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCT… |
Heteromer | 100 | ||||
| NMR structure of human insulin mutant His-B10-Asp, Pro-B28-Lys, Lys-B29-Pro, 20 structures |
Heteromer | 100 | ||||
| Biosynthetic engineered A21K-B31K-B32R human insulin monomer structure in water/acetonitrile soluti… |
Heteromer | 95.24 | ||||
| Humal Insulin Mutant B31Lys-B32Arg |
Heteromer | 100 | ||||
| Human Insulin Mutant A22Gly-B31Lys-B32Arg |
Heteromer | 100 | ||||
| Structure of [D-HisB24] insulin analogue at pH 1.9 |
Heteromer | 100 | ||||
| NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 struct… |
Heteromer | 100 | ||||
| Structure of [D-HisB24] insulin analogue at pH 8.0 |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCT… |
Heteromer | 100 | ||||
| Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 1.9 |
Heteromer | 100 | ||||
| Solution structure of [GlyB24,B27-B29 triazole cross-linked]-insulin analogue at pH 1.9 |
Heteromer | 100 | ||||
| B24Y DKP insulin |
Heteromer | 100 | ||||
| AbaA3-DKP-insulin |
Heteromer | 95.24 | ||||
| human insulin receptor ectodomain bound by 4 insulin |
Heteromer P06213; | 100 | ||||
| NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Str… |
Heteromer | 100 | ||||
| NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Str… |
Heteromer | 85.71 | ||||
| Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solution… |
Heteromer | 100 | ||||
| INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES |
Heteromer | 95.24 | ||||
| Structure of [L-HisB24] insulin analogue at pH 8.0 |
Heteromer | 100 | ||||
| INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES |
Heteromer | 100 | ||||
| Enhancing the activity of insulin by stereospecific unfolding |
Heteromer | 100 | ||||
| Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 8.0 |
Heteromer | 100 | ||||
| Solution structure of [GlnB22]-insulin mutant at pH 1.9 |
Heteromer | 100 | ||||
| Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions. |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCT… |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTU… |
Heteromer | 95.24 | ||||
| Structure of [L-HisB24] insulin analogue at pH 1.9 |
Heteromer | 100 | ||||
| Biosynthetic engineered A22S-B3K-B31R human insulin monomer structure in water/acetonitrile solutio… |
Heteromer | 100 | ||||
| tentative model of the human insulin receptor ectodomain bound by three insulin |
Heteromer P06213; | 100 | ||||
| NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structur… |
Heteromer | 100 | ||||
| HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES |
Heteromer | 100 | ||||
| Receptor binding redefined by a structural switch in a mutant Human Insulin |
Heteromer | 100 | ||||
| MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRU… |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN under Amyloidogenic Condition, 15 STRUCTURES |
Heteromer | 100 | ||||
| Dynamics of insulin probed by 1H-NMR amide proton exchange anomalous flexibility of the receptor-bi… |
Heteromer | 100 | ||||
| SOLUTION STRUCTURE OF THE SUPERACTIVE MONOMERIC DES-[PHE(B25)] HUMAN INSULIN MUTANT. ELUCIDATION OF… |
Heteromer | 100 | ||||
| NMR structure of human insulin monomer in 35% CD3CN zinc free, 50 structures |
Heteromer | 100 | ||||
| FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA |
Heteromer | 100 | 2×ZN; 2×CL; 1×NA; | |||
| Solution structure of the monomeric [Thr(B27)->Pro,Pro(B28)->Thr] insulin mutant (PT insulin) |
Heteromer | 100 | ||||
| Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists |
Heteromer P06213; | 100 | 4×NAG; 2×NAG; 2×NAG; 2×NAG; 4×NAG; | |||
| Cryo-EM structure of the IGF1R/insulin complex |
Heteromer P08069; | 100 | 4×NAG; | |||
| The T2 structure of polycrystalline cubic human insulin |
Heteromer | 100 | ||||
| Human insulin analog: [GluB10,TyrB20]-DOI |
Heteromer | 100 | ||||
| Human insulin analog: [GluB10,HisA8,ArgA9,TyrB20]-DOI |
Heteromer | 90.0 | ||||
| Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0 |
Heteromer | 100 | 1×NA; | |||
| Semi-synthetic highly active analogue of human insulin NMeAlaB26-DTI- NH2 |
Heteromer | 100 | 4×ACT; | |||
| Semi-synthetic analogue of human insulin NMeTyrB26-insulin in monomer form |
Heteromer | 100 | 2×ACT; | |||
| Insulin glargine crystal structure 1 |
Heteromer | 100 | ||||
| X-Ray structure of Insulin Glargine |
Heteromer | 100 | ||||
| Crystal structure of the B24His-insulin - human analogue |
Heteromer | 100 | 1×SO4; | |||
| Human insulin trans-HypB26-DTIA analogue |
Heteromer | 96.0 | 1×SO4; | |||
| Despentapeptide insulin in acetic acid (pH 2) |
Heteromer | 100 | 3×SO4; | |||
| Insulin glargine crystal structure 2 |
Heteromer | 100 | ||||
| Crystal structure of human insulin trans-HypB26-DTI analogue |
Heteromer | 100 | 2×SO4; 1×IPH; | |||
| Semi-synthetic analogue of human insulin ProB26-DTI in monomer form |
Heteromer | 100 | ||||
| Crystal structure of lisargine |
Heteromer | 100 | 2×ZN; 2×CL; | |||
| Insulin with proline analog ThioP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; | |||
| Human insulin in complex with serotonin and arginine |
Heteromer | 100.0 | 6×ZN; 6×CL; 3×ARG; 3×SRO; | |||
| Semi-synthetic highly active analogue of human insulin NMeHisB26-DTI- NH2 |
Heteromer | 100 | 2×ACT; | |||
| Semi-synthetic highly active analogue of human insulin D-ProB26-DTI- NH2 |
Heteromer | 100 | ||||
| Crystal structure of human insulin-degrading enzyme in complex with insulin |
Heteromer P14735; | 100 | 1×ZN; | |||
| Human insulin B26Gly mutant crystal structure |
Heteromer | 100 | 1×SO4; | |||
| Insulin triple mutant INS-RQD |
Heteromer | 100 | ||||
| Structure of Glargine insulin in 20% acetic acid-d4 (pH 1.9) |
Heteromer | 100 | ||||
| INSULIN MUTANT (B1, B10, B16, B27)GLU, DES-B30, NMR, 25 STRUCTURES |
Heteromer | 100 | ||||
| Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 1 In… |
Heteromer P06213; | 100.0 | ||||
| Full-length insulin receptor bound with unsaturated insulin WT (2 insulins bound) asymmetric confor… |
Heteromer P15208; | 100.0 | ||||
| Full-length insulin receptor bound with site 2 binding deficient mutant insulin (B-L17R) -- symmetr… |
Heteromer P15208; | 96.3 | ||||
| Full-length insulin receptor bound with unsaturated insulin WT (1 insulin bound) asymmetric conform… |
Heteromer P15208; | 100.0 | ||||
| Full-length insulin receptor bound with unsaturated insulin WT (2 insulins bound) asymmetric confor… |
Heteromer P15208; | 100.0 | ||||
| Cryo-EM Structure for the Insulin Binding Region in the Ectodomain of the Full-length Human Insulin… |
Heteromer P06213; | 100.0 | ||||
| Full-length insulin receptor bound with site 2 binding deficient mutant insulin (A-L13R) -- asymmet… |
Heteromer P15208; | 100 | ||||
| Cryo-EM structure of 4 insulins bound full-length mouse IR mutant with physically decoupled alpha C… |
Heteromer P15208; | 100.0 | ||||
| Cryo-EM structure of 4 insulins bound full-length mouse IR mutant with physically decoupled alpha C… |
Heteromer P15208; | 100.0 | ||||
| Full-length insulin receptor bound with unsaturated insulin WT (2 insulin bound) symmetric conforma… |
Heteromer P15208; | 100.0 | ||||
| Full-length insulin receptor bound with site 2 binding deficient mutant insulin (A-L13R) -- symmetr… |
Heteromer P15208; | 100 | ||||
| Cryo-EM structure of 4 insulins bound full-length mouse IR mutant with physically decoupled alpha C… |
Heteromer P15208; | 100.0 | ||||
| Full-length insulin receptor bound with site 2 binding deficient mutant insulin (B-L17R) -- asymmet… |
Heteromer P15208; | 96.3 | ||||
| Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 2 In… |
Heteromer P06213; | 100.0 | ||||
| Full-length insulin receptor bound with both site 1 binding deficient mutant insulin (A-V3E) and si… |
Heteromer P15208; | 100 | ||||
| Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)ami… |
Heteromer | 95.24 | 4×NO3; | |||
| The crystal structure of a human seleno-insulin analog |
Heteromer | 90.48 | ||||
| Crystal structure form ultalente insulin microcrystals |
Heteromer | 100 | 12×ZN; 3×MPB; | |||
| Human insulin in complex with the analytical antibody OXI-005 Fab |
Heteromer | 100 | ||||
| The insulin receptor ectodomain in complex with four venom hybrid insulins - symmetric conformation |
Heteromer P06213; | 95.24 | 20×NAG; | |||
| Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin with visible dd… |
Heteromer P06213; | 100 | ||||
| The insulin receptor ectodomain in complex with a venom hybrid insulin analog - "head" region |
Heteromer P06213; | 95.24 | 2×NAG; 12×NAG; | |||
| The insulin receptor ectodomain in complex with three venom hybrid insulin molecules - asymmetric c… |
Heteromer P06213; | 95.24 | ||||
| Leucine-zippered human insulin receptor ectodomain with single bound insulin - "upper" membrane-dis… |
Heteromer P06213; | 100 | 1×NAG; 9×NAG; | |||
| Low resolution Cryo-EM structure of the full-length insulin receptor bound to 2 insulin, conf 3 |
Heteromer P06213; | 100 | ||||
| Insulin receptor ectodomain dimer complexed with two IRPA-3 partial agonists |
Heteromer P06213; | 100 | ||||
| Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin, conf 1 |
Heteromer P06213; | 100 | ||||
| Low resolution Cryo-EM structure of the full-length insulin receptor bound to 3 insulin, conf 2 |
Heteromer P06213; | 100 | ||||
| Cryo-EM structure of human insulin degrading enzyme in complex with insulin |
Heteromer P14735; | 100.0 | ||||
| Head region of insulin receptor ectodomain (A-isoform) bound to the non-insulin agonist IM462 |
Heteromer P06213; | 100 | 1×NAG; 6×NAG; | |||
| Cryo-EM structure of the full-length human IGF-1R in complex with insulin |
Heteromer P08069; | 100 | 4×NAG; 1×NAG; 6×NAG; | |||
| Insulin Degrading Enzyme pO/pC |
Heteromer P14735; | 100 | ||||
| Insulin Degrading Enzyme pC/pC |
Heteromer P14735; | 100 | ||||
| Full-length insulin receptor bound with site 1 binding deficient mutant insulin (A-V3E) |
Heteromer P15208; | 100 | ||||
| Human insulin in complex with the analytical antibody HUI-018 Fab |
Heteromer | 100 | ||||
| Insulin Degrading Enzyme O/pC |
Heteromer P14735; | 100.0 | ||||
| Cryo-EM structure of insulin amyloid-like fibril that is composed of two antiparallel protofilaments |
Heteromer | 100 | ||||
| Insulin in complex with Site 1 of the human insulin receptor |
Heteromer P06213; | 100 | 1×NAG; 1×NAG; 3×NAG; | |||
| Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha… |
Heteromer P06213; | 100 | 1×NAG; 1×NAG; 3×NAG; | |||
| Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… |
Heteromer P06213; | 100 | 1×NAG; 1×NAG; 2×NAG; | |||
| Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… |
Heteromer P06213; | 100 | 1×NAG; 1×NAG; 2×NAG; | |||
| Cryo-EM structure of human insulin degrading enzyme in complex with insulin |
Heteromer P14735; | 100.0 | ||||
| crystal structure of human insulin-degrading enzyme in complex with insulin B chain |
Heteromer P14735; | 100.0 | 1×DIO; | |||
| Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry |
Heteromer P01318; P06213; | 100 | 4×NAG; 2×NAG; 2×NAG; 2×NAG; 4×NAG; | |||
| human insulin receptor bound with A43 DNA aptamer and insulin |
Heteromer F8WCM5; P06213; | 100 | ||||
| Insulin Receptor ectodomain in complex with one insulin molecule |
Heteromer P01318; P06213; | 100 | ||||
| human insulin receptor bound with A62 DNA aptamer and insulin - locally refined |
Heteromer F8WCM5; P06213; | 100 | ||||
| Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-… |
Heteromer P0DOX5; P14735; Q6GMX0; | 100 | ||||
| Insulin Receptor ectodomain in complex with two insulin molecules |
Heteromer P01318; P06213; | 100 | 4×NAG; 2×NAG; 2×NAG; 2×NAG; 4×NAG; | |||
| human insulin receptor bound with two insulin molecules |
Heteromer F8WCM5; P06213; | 100 | ||||
| human insulin receptor bound with A62 DNA aptamer and insulin |
Heteromer F8WCM5; P06213; | 100 | ||||
| Crystal structure of Zn-bound human insulin-degrading enzyme in complex with insulin B chain |
Heteromer P14735; | 100.0 | 1×ZN; 1×DIO; | |||
| Crystal Structure Analysis of Fab1-Bound Human Insulin Degrading Enzyme (IDE) in Complex with Insul… |
Heteromer P14735; | 100 | 2×ZN; | |||
| Crystal Structure Analysis of Elbow-Engineered-Fab-Bound Human Insulin Degrading Enzyme (IDE) in Co… |
Heteromer P14735; | 100.0 | 2×EPE; 2×ZN; | |||
| Human TCR A2.13 in complex with DQ8-InsCpep |
Heteromer O19707; Q30069; | 86.67 | 1×NAG; 2×NAG; 1×PO4; 5×GOL; | |||
| Crystal structure of Proinsulin C-peptide bound to HLA-DQ8 |
Heteromer O19707; Q30069; | 86.67 | 1×NAG; 1×GOL; | |||
| immune complex |
Heteromer P01903; P01911; | 100 | 1×NAG; | |||
| Crystal structure of a human insulin peptide-HLA-DQ8 complex |
Heteromer P01909; P01920; | 100 | 1×NAG; | |||
| immune complex |
Heteromer P01903; P01911; | 100 | 1×NAG; 1×NAG; 3×MLI; | |||
| Human HLA-A*0201-ALWGPDPAAA |
Heteromer P04439; P61769; | 100 | ||||
| HLA-A02 carrying AQWGPDPAAA |
Heteromer P04439; P61769; | 90.0 | ||||
| Weak TCR binding to an unstable insulin epitope drives type 1 diabetes |
Heteromer P01902; P61769; | 100 | 3×EDO; 2×GOL; 4×SO4; | |||
| 1E6-A*0201-ALWGPDPAAA Complex, Triclinic |
Heteromer P04439; P61769; | 100 | ||||
| 1E6-A*0201-ALWGPDPAAA Complex, Monoclinic |
Heteromer P04439; P61769; | 100 | 2×SO4; | |||
| 1E6 TCR in Complex with HLA-A02 carrying AQWGPDPAAA |
Heteromer A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P04439; P61769; | 90.0 | ||||
| Weak TCR binding to an unstable insulin epitope drives type 1 diabetes |
Heteromer P01902; P61769; | 88.89 | 4×GOL; 1×15P; 7×EDO; 2×SO4; | |||
| Weak TCR binding to an unstable insulin epitope drives type 1 diabetes |
Heteromer P01902; P61769; | 88.89 | 5×EDO; 2×GOL; 4×SO4; | |||
| Weak TCR binding to an unstable insulin epitope drives type 1 diabetes |
Heteromer P01902; P61769; | 100 | 1×EDO; 3×SO4; | |||
| Human MHC Class I, A24 Allele presenting LWM, Complex with 4C6 TCR |
Heteromer A0A5H2UYS3; P61769; | 100 | 3×SO4; 1×EPE; 3×EDO; | |||
| VEALYL peptide derived from human insulin chain B, residues 12-17 | homo-8-mer | 100 | ||||
| Crystal structure of human insulin desB30 precursor with an Alanine-Methionine-Lysine C-peptide in … | homo-6-mer | 100 | 12×ZN; 3×CL; 3×RCO; | |||
| Des-B29,B30-insulin | homo-6-mer | 96.43 | 6×IPH; 2×ZN; 2×CL; | |||
| An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological si… | homo-6-mer | 100.0 | ||||
| LVEALYL peptide derived from human insulin chain B, residues 11-17 | homo-4-mer | 100 | ||||
| Crystal structure of human insulin desB30 precursor with an Alanine-Methionine-Lysine C-peptide in … | homo-2-mer | 100 | ||||
| Crystal structure of human insulin desB30 precursor with an Aspartate-Glycine-Lysine C-peptide in d… | homo-2-mer | 100 | ||||
| Crystal structure of human insulin desB30 precursor with an Alanine-Alanine-Lysine C-peptide in dim… | homo-2-mer | 100 | ||||
| Crystal structure of the monomeric zinc free human insulin A22K, B3E, B26E, B29R, desB30 precursor … | monomer | 89.66 | ||||
| MINI-PROINSULIN, SINGLE CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP AND PEPTID… | monomer | 93.1 | ||||
| Design of an Active Ultra-Stable Single-Chain Insulin Analog 20 Structures | monomer | 90.0 | ||||
| NMR Structure of Proinsulin | monomer | 96.51 | ||||
| AN ACTIVE MINI-PROINSULIN, M2PI | monomer | 89.19 | ||||
| NMR Structures of Single-chain Insulin | monomer | 90.0 | ||||
| Solution Structure and Dynamics of an Ultra-Stable Single-Chain Insulin Analog STUDIES OF AN ENGINE… | monomer | 93.33 | ||||
| Solution Structure of a Heat-Resistant Long-Acting Insulin Analog | monomer | 93.55 | ||||
| Solution Structure of Human Proinsulin C-Peptide | monomer | 100 | ||||
| Highly biologically active insulin with additional disulfide bond | monomer | 95.24 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2lwz.1.A | monomer | 0.52 | 91.23 | |||